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Purpose: The Asymptomatic Carotid Atherosderosis Study (ACAS) indicated significant 
benefit from endarterectomy compared with medical therapy for patients with 60% to 99% 
asymptomatic internal carotid artery (ICA) stenoses. To date, optimal selection of patients 
for vascular laboratory foUow-up to determine progression from <60% to ->60% asymp- 
tomatic ICA stenosis is unknown. To determine which patients with <60% asymptomatic 
ICA stenoses are at greatest risk for short-term progression to ->60% without symptoms, 
we reviewed vascular laboratory results and clinical risk factors of consecutive patients who 
were prospectively observed in a study of atherosderosis progression. 
Methods: Carotid duplex studies were obtained every 6 months and were reviewed for 
progression from <60% to ->60% asymptomatic ICA stenosis by using criteria that were 
developed and reported by our laboratory. Clinical risk factors and velocities from initial 
duplex scans were analyzed for association with progression from <60% to ->60% ICA 
stenoses without symptoms. 
Results: Two hundred sixty-three patients (mean age, 66 years) with 434 asymptomatic 
<60% ICA stenoses were prospectively observed for a mean of 20 months, with a mean of 
four examinations per patient. Seventeen patients (6.5%) and 18 ICAs (4%) progressed 
without symptoms to ->60% ICA stenoses at a mean of 18 months. Clinical risk factors 
associated with progression to ->60% asymptomatic ICA stenosis included elevated systolic 
blood pressure and decreased anlde-braehial ndex (p = 0.05). The mean initial ICA peak 
systolic velocity (PSV) in ICAs that progressed to >60% asymptomatic stenoses was 180 
cm/sec, compared with 104 cm/sec in asymptomatic ICAs that did not progress to ->60% 
(p = 0.0003). Thirty-one percent of asymptomatic ICAs that had initial PSVs of 175 
cm/sec or greater progressed to->60% stenosis, whereas only 1.8% that had initial PSVs less 
than 175cm/sec progressed to ->60% asymptomatic stenoses (p < 0.001). The life- 
table-determined rate of freedom from progression to->60% stenosis was 94% at 4 years for 
asymptomatic ICA lesions that had initial PSVs less than 175 cm/sec, compared with 14% 
at 3 years for lesions that had initial PSVs ->175 cm/sec. 
Conclusions: Early progression from <60% asymptomatic ICA stenoses to ->60% asymptom- 
atic ICA stenoses occurs infrequently. Patients who are at the greatest risk of early progres- 
sion without symptoms to an ACAS-positive lesion can be identified from the ICA PSV at 
their initial duplex examination. Early vascular laboratory follow-up of asymptomatic ICA 
stenoses may be limited to a relatively small group. (J Vasc Surg 1996;24:580-7.) 
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The Asymptomatic Carotid Atherosclerosis Study 
(ACAS) demonstrated benefit from prophylactic ca- 
rotid endarterectomy for patients who have >60% 
asymptomatic internal carotid artery (ICA) stenoses.1 
Because these lesions are asymptomatic, their detec- 
tion requires acarotid screening study, usually duplex 
scanning. Most screening studies do not reveal a >60% 
stenosis, 2-4 and these patients must then be consid- 
ered for further follow-up. Although it is known that 
ICA stenoses generally worsen over time, 5-9 the spe- 
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cific question of which <60% stenoses are most likely 
to progress to ACAS-threshold lesions (_>60% 
stenoses) has not been addressed. This information 
would be useful in constructing uidelines for the 
vascular laboratory follow-up of patients who have 
lmown, but <60%, ICA stenoses. 
We recently reported duplex criteria that pre- 
dicted the presence of a _>60% angiographic ICA 
stenosis with 90% overall accuracy and a positive 
predictive value of92%) ° In this study we report he 
results of the prospective follow-up of 263 patients 
who had known peripheral vascular disease and whose 
asymptomatic carotid artery stenoses were evaluated 
by serial duplex scanning. The goal was to determine 
patient-specific and duplex-specific variables that 
identified the patients who had <60% ICA stenoses 
that were most likely to progress without symptoms 
to _>60% ICA stenoses. 
PATIENTS AND METHODS 
Since 1991 we have enrolled patients in a prospec- 
tive longitudinal study of atherosclerotic disease pro- 
gression,  Eligible patients include those 40 to 80 
years of age who have symptomatic atherosclerotic 
vascular disease (defined as a history of claudication, 
rest pain, ischemic ulceration, previous infrainguinal 
bypass, transient ischemic attacks, stroke, or carotid 
endarterectomy). When entered into the study, pa- 
tients undergo a cardiovascular-directed history and 
physical examination and vascular laboratory evalua- 
tion. Vascular laboratory studies include segmental 
leg blood pressure measurements, readmill test, and 
carotid duplex scanning. Duplex scans are performed 
in a standard fashion 12 with an Acuson 128 duplex 
scanner (Acuson Inc., Mountain View, Calif.). All 
patients undergo a clinical laboratory evaluation, 
which includes tests for serum electrolytes, blood urea 
nitrogen, creatinine, blood glucose, fasting choles- 
terol, and triglyceride levels, as well as white blood 
cell, hemoglobin, hematocrit, and platelet counts. 
Coagulation studies that are routinely obtained in- 
clude tests for prothrombin and partial thromboplas- 
tin times and anticardiolipin antibody, antithrombin 
III, protein C, protein S, and lipoprotein (a) levels. 
The taking of history, physical examination, and 
vascular laboratory tests are repeated every 6 months. 
For this study all enrolled patients at study entry 
who had at least one asymptomatic <60% ICA 
stenoses that remained asymptomatic during fol- 
low-up were analyzed. Duplex examinations of 
asymptomatic <60% ICAs taken at the time the 
patient entered the study were reviewed to identify 
patients whose ICAs progressed to _>60% asymptom- 
atic stenosis during follow-up. Duplex distinction 
bctwccn <60% and _>60% ICA stcnoses was made on 
the basis of criteria that were previously published in 
a combined study from our institution and the Uni- 
versity of Washington. 1°Specifically, the combination 
ofa ICA peak systolic velocity (PSV) greater than 260 
cm/sec and an end-diastolic velocity greater than 70 
cm/sec (92% positive predictive value) was used to 
identify a _>60% ICA stenosis. Serial duplex examina- 
tions were reviewed to detect patients in whom 
_>60% asymptomatic ICA stenoses developed uring 
follow-up. 
Paticnts who had asymptomatic ICA stenoses that 
progressed without symptoms to _>60% ICA stenoses 
during follow-up were compared with patients whose 
stenosis did not progress to a _>60% asymptomatic 
stenosis. Thcsc comparisons included age, sex, lipid 
levels, the prcscncc or absence of diabctcs mellitus 
(receiving oral hypoglycemic agents or insulin), 
smoking (current or quit), systolic blood pressure, 
ankle-brachial index (ABI) at study entrance, the 
presence of known coronary artery disease (history of 
myocardial infarction, angina pectoris, coronary ar- 
tery bypass grafting procedure, transluminal coronary 
angioplasty, or congestive heart failure), presence of 
renal insufficiency (dialysis-dependent or creatinine 
level >2.0 mg/dl), or a hypercoagulable disorder. In 
addition, the presence of contralateral carotid symp- 
toms or contralateral carotid occlusion when entered 
into the study and their development during fol- 
low-up were also compared. 
Initial carotid duplex studies were analyzed for 
duplex variables (ICA PSV, end-diastolic velocity, and 
ICA/common carotid artery [CCA] PSV ratio) asso- 
ciated with subsequent progression to >60% ICA 
stenosis without symptoms. 
Data were stored in a Dataease file management 
database (Dataease Inc., Trumbull, Conn.). The 
significance of associations among variables was ana- 
lyzed with two-way contingency tablcs and Z 2 tests for 
categoric variables. Comparison between two groups 
was analyzed by a two-sample Student t test for 
continuous variables. The probability of various fac- 
tors influencing the progression of ICA stenosis was 
assessed by multivariate, stepwisc logistic regression 
analysis with the statistical analysis system package 
(SAS Institute; Cary, N.C.). The log-rank method 
was used to compare life-table results. 13 Results were 
considered significant ifp < 0.05. 
RESULTS 
Patients and ICA progression. Two-hundred 
sixty-three patients who had 434 asymptomatic ICAs 
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Fig. 1. Four-year life-table-determined rateof freedom from progression to>60% stenosis n
399 asymptomatic ICAs with <60% stenosis and initial PSVs less than 175 cm/sec. 
Table I. Clinical risk factors for asymptomatic progression form <60% to ---60% ICA stenosis 
Risk factor Progressors (SD) Nonprogressors (SD) p * 
Age (mean) 69 66 0.11 
Men 65% 63% 0.86 
Smoking 94% 82% 0.44 
Diabetes 24% 22% 0.88 
Cardiac disease 53% 48% 0.67 
Contralateral symptoms 47% 31% 0.18 
Creatinine l vel _>2.0 mg/dl 0% 2.4% 0.52 
Positive hypercoaguable state screening 5.9% 3.7% 0.64 
ABI (mean) 0.74 + 0.18 0.85 + 0.22 0.05 
Systolic blood pressure (mm Hg) 164 + 21 153 + 23 0.05 
Triglyceride levels (mg/dl) 262 + 172 230 + 150 0.46 
Cholesterol level (mg/dl) 211 + 43 220 + 44 0.42 
*Logistic regression analysis. 
were prospectively observed for a mean of 20 months 
(range, 6 to 42 months). Two hundred forty-six 
patients (94%) had 416 asymptomatic ICAs (96%) 
that remained <60% stenotic, as compared with 17 
patients (6%) with 18 asymptomatic ICAs (4%) that 
progressed to ___60% ICA stenosis during follow-up. 
Of the 17 patients who had an ICA that progressed to
_>60% stenosis during follow-up, eight underwent 
carotid endarterectomy after consultation with their 
referring physician. Preoperative angiography con- 
firmed a ->60% ICA stenosis in all patients who 
underwent surgery. No perioperative strokes or 
deaths occurred. Nine patients whose asymptomatic 
ICA progressed to _>60% stcnosis continue to be 
observed, and all remain without symptoms. Serial 
duplex studies for the nine patients who did not 
undergo surgery after progression to _>60% asymp- 
tomatic ICA stenosis had PSVs of 260 cm/sec or 
greater in 23 of 28 follow-up studies. Three of the 
asymptomatic ICAs that progressed and did not 
undergo carotid endarterectomy vacillated above and 
below the cutoffPSV of 260 cm/sec during follow-up 
and likely represented borderline l sions. 
Clinical risk factor analysis. A comparison of 
clinical risk factors between patients who had asymp- 
tomatic ICA progression to>60% stenoses and those 
who did not are shown in Table I. Patients whose ICA 
progressed to ___60% asymptomatic stenosis during 
follow-up had a significantly greater systolic blood 
pressure (p = 0.05) and a lower initial resting ABI 
(p = 0.05) than those patients whose asymptomatic 
ICAs remained <60% stenotic. 
Duplex analysis. A mean of four carotid duplex 
examinations per patient were performed uring 
follow-up (range, two to seven). When entered into 
the study, there were two contralateral ICA occlu- 
sions (11%) in the patients who had a <60% ICA 
stenosis progress to _>60% stenosis, compared with 
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Fig. 2. Three-year life-table-determined rateof freedom from progression to___60% stenosis in
35 asymptomatic ICAs with <60% stenosis and initial PSVs 175 cm/sec or greater. 
Table II. Rate of freedom from progression from <60% asymptomatic ICA stenosis to _>60% 
asymptomatic ICA stenosis (initial ICA PSV <175 cm/sec) 
Interval (too) At  risk Progress Withdrawn Interval stable Cumulative stable SE 
0 399 0 0 1.000 1.000 0.0000 
6 399 0 75 1.000 1.000 0.0054 
12 324 1 96 0.996 0.996 0.0035 
24 227 4 118 0.976 0.972 0.0108 
36 105 2 70 0.944 0.944 0.0218 
48 33 0 33 1.000 0.944 0.0389 
10 contralateral ICA occlusions (2.4%) in the 416 
ICAs that remained <60% (p=0.14). No <60% 
asymptomatic ICA stenosis progressed to occlusion 
during follow-up. 
The mean initial ICA PSVwas 180 + 63.3 cm/sec 
in the 18 asymptomatic <60% stenotic ICAs that 
progressed without symptoms to >60% stenoses, 
compared with a mean initial PSV of 104 + 39 
cm/sec in the 416 asymptomatic ICAs that remained 
<60% during follow-up (p = 0.0003). The mean ini- 
tial ICA/CCA PSV ratio was 2.39 + 1.12 in the 18 
asymptomatic <60% stenotic ICAs that progressed to
>60% stenosis, compared with a mean initial 
ICA/CCA PSV ratio of 1.41 + 0.71 in the 416 
asymptomatic ICAs that remained <60% during fol- 
low-up (p < 0.001). End-diastolic velocity alone did 
not correlate with progression from <60% to >60% 
ICA stenosis. 
Thirty-one percent of asymptomatic ICAs that 
had initial PSVs of 175 cm/sec or greater progressed 
to >60% asymptomatic stenoses, compared with only 
1.8% of asymptomatic ICAs that had initial PSVs less 
than 175 cm/sec (p < 0.001). The life-table-deter- 
mined rate of freedom from progression to_>60% ICA 
stenosis for the <60% asymptomatic ICAs that had 
initial PSVs less than 175 cm/sec was 100% at I year 
and 94% at 4 years (Table II, Fig. 1). The life- 
table-determined rate of freedom from progression 
to _>60% ICA stenosis for those <60% asymptomatic 
ICAs that had initial PSVs of 175 cm/sec or greater 
was 91% at one year and 14% at 3 years (Table III, Fig. 
2; p < 0.0005). 
DISCUSSION 
Several studies have used duplex scanning to 
examine the progression of asymptomatic ICA 
stenoses, -9 The studies are summarized in Table IV. 
These reports document that in the intermediate term 
a minority of carotid stenoses progress and that only 
a small number (<10%) of these stenoses will have 
symptoms. Most investigators have noted that greater 
degrees of carotid stenosis are associated with a higher 
risk of symptoms, occlusion, or both. No study to 
date, however, has specifically addressed the question 
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Table III. Rate of freedom from progression from <60% asymptomatic ICA stenosis to >60% 
asymptomatic IGA stenosis (initial IGA PSV _>175 cm/sec) 
Interval (mo) At  risk Progress Withdrawn Interval stable Cumulative stable SE 
0 35 0 0 1.000 1.000 0.0000 
6 35 0 6 1.000 1.000 0.0054 
12 29 2 12 0.913 0.913 0.0500 
24 15 3 4 0.769 0.702 0.0989 
36 8 6 1 0.200 0.140 0.0459 
Table IV. Additional reports examining the natural history of asymptomatic ICA stenosis 
Date Author n Mean follow-up Percent progression TIA Stroke Occlusion 
1984 Roederer 167 36 too.* 60%~ 6 (3.6%) 4 (2.4%) 10 (6%) 
1990 Norris 696 41 too. Not given 75 (11%) 29 (4.2%) Not given 
1992 Ellis 1198 20 mo. 3.1%:~ 33 (2.8%) 27 (2.3%) Not given 
1992 Shanik 188 48 too. 28.6% 6 (3.2%) 10 (5.3%) 12 (6.4%) 
1993 Bock 242 27 too. Not given . 20 (8.3%) 15 (6.2%) Not given 
1995 Johnson 232 84 mo.§ 23%z~ Not given 12 (5.2%) 10 (4.3%) 
*Mean follow-up not given (patients studied for up to 36 months). 
1"Defined as a change in carotid stenosis of one or more spectral categories. 
1:Defined as development of >50% stenosis. 
§Mean follow-up not given (life table data available for 7 years). 
of which patients who have asymptomatic ICA 
stenoses are most likely to progress without symp- 
toms to the threshold level of ICA stenosis that was 
identified by ACAS as statistically benefiting from 
prophylactic carotid endarterectomy. 
With the results of the ACAS study many physi- 
cians may wish both to detect asymptomatic ICAs 
between 60% and 99% stenosis and to establish aplan 
for vascular laboratory follow-up for patients who 
have known atherosclerotic disease but <60% asymp- 
tomatic ICA stenosis. Accordingly, we developed 
vascular laboratory criteria that specifically address the 
ACAS threshold level oflCA stenosis. 1° Our current 
study used these criteria in a prospectively observed 
cohort with <60% asymptomatic ICA stenosis to 
develop guidelines for vascular laboratory follow-up 
of these patients. 
Although clinical risk factors for progression from 
<60% asymptomatic ICA stenosis to _>60% ICA steno- 
sis in this study included both an elevated systolic 
blood pressure and a low ABI, the data presented 
herein indicate that the schedule for vascular labora- 
tory follow-up of asymptomatic ICA stenoses that 
occur in patients who have symptomatic atheroscle- 
rotic vascular disease can probably be best based on 
initial carotid artery duplex findings. Patients who 
have ICA peak systolic velocities less than 175 cm/sec 
have very little risk of the stenosis progressing to a 
_>60% asymptomatic ICA stenosis in the intermediate 
term; in our experience only 5.6% of stenoscs pro- 
gressed to an ACAS-threshold lesion within 4 years 
after their screening carotid duplex examination. It 
therefore appears appropriate to delay subsequent 
carotid uplex examinations in such patients for 3 or 
4 years, provided that hey remain without symptoms. 
Even patients who have a stenosis and whose initial 
ICA peak systolic velocity is greater than 175 cm/sec 
are at low risk for progression without symptoms to a 
_>60% ICA stenosis at 1 year, but by 3 years 86% of 
these patients will have their stenosis progress from 
<60% to a _>60% asymptomatic ICA stenosis. It would 
appear prudent for these patients to undergo fol- 
low-up carotid artery duplex studies at least yearly 
provided that they remain a clinical candidate for 
prophylactic carotid endarterectomy. 
The high rate of progression to _>60% asymptom- 
atic ICA stenosis for ICAs that have peal~ systolic 
velocities greater than 175 cm/scc may, in part, be 
explained by the patient cohort included in the study. 
To bc included in the study, all of the patients (those 
whose stenoses progressed and those whose stenoses 
did not) had sufficiently advanced atherosclerotic 
arterial disease to have produced symptoms in the 
opposite carotid artery or in the legs. The patients 
may therefore be preselected for their arterial disease 
to progress once it reaches a certain level. The 
recommendations for carotid duplex follow-up ex- 
aminations that were stated above may in fact be too 
liberal for patients who have no symptoms of arterial 
disease and a <60% asymptomatic ICA stenosis de- 
tected on duplex scanning. Clearly additional studies 
that examine the progression of asymptomatic ICA 
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stenosis in different vascular disease cohorts will be 
useful in opt imiz ing recommendat ions  for fol low-up 
carotid u l trasound studies. For  the present, in patients 
who have symptomatic  arterial disease, we recom- 
mend that more frequent fol low-up o f  patients who 
have asymptomatic <60% ICA stenosis be per formed 
if the patients have initial ICA  peak systolic velocities 
greater than 175 cm/sec .  
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DISCUSSION 
Dr. R. Eugene Zierler (Seattle, Wash.). Randomized 
clinical trials such as the North American Symptomatic 
Carotid Endarterectomy Trial and ACAS have provided us 
with specific linical guidelines regarding the indications for 
performing carotid endarterectomy in patients who have 
symptomatic or asymptomatic carotid artery disease. In 
these trials, a particular degree of carotid stenosis everity 
emerged as the threshold for recommending surgical treat- 
ment. The results of these trials, however, are not much help 
in establishing the optimal protocols for managing patients 
who have degrees of carotid stenosis that are below the 
surgical threshold. Furthermore, those clinical trials only 
documented the severity of carotid artery disease at the 
point of randomization, ot at the time a subsequent 
neurologic event occurred. Thus the actual degree of 
stenosis that is associated with neurologic events remains 
unknown unless arteriographic or duplex scans are re- 
peated. 
Changes in the severity of carotid artery disease over 
time are clearly of critical importance in determining the 
most appropriate follow-up protocol for patients who have 
mild to moderate degrees ofasymptomatic carotid stenosis. 
Natural history studies provide the basic information that is 
necessary for establishing these protocols. Ideally, natural 
history studies of atherosclerosis hould indicate both the 
frequency and the rate of disease progression, as well as any 
factors associated with an increased risk of disease progres- 
sion or clinical events. 
This report addresses the issue of patients who have 
asymptomatic carotid artery disease and have lesions that do 
not meet he threshold for surgical treatment according to 
ACAS. A cohort of patients that met these general criteria 
was identified, and the patients were observed at 6-month 
intervals by previously validated uplex criteria. The PSV at 
the site of the lesion was found to be the most predictive 
parameter for progression from <60% to _>60% ICA stenosis. 
The threshold value of 175 cm/sec appeared to reliably 
identify patients who had mild to moderate carotid disease 
and who were most likely to progress over time and meet he 
ACAS criteria for undergoing carotid endarterectomy. 
These results are consistent with a similar natural history 
study from our own group that was published in the Journal 
of Vascular Surgery last year. 6That study used serial duplex 
scans to evaluate carotid artery disease progression i 232 
asymptomatic patients who had <80% stenoses and were 
observed for as many as 10 years. The cumulative risk of 
JOURNAL OF VASCULAR SURGERY 
586 Nehler et al. October 1996 
progression to >80% stenosis was related to the initial 
severity of carotid disease, with 27% of the 50%-to-79% 
lesions but only 4% of the <50% lesions howing progression 
to >80% stenosis over 7 years. Thus the annual rate of 
progression to >80% stenosis was 3.7% for 50%-to-79% 
stenoses and 0.6% for <50% carotid lesions. These findings 
led to the recommendation forat least annual follow-up for 
patients who have asymptomatic 50%-to-79% carotid 
stenoses and follow-up at 2-year intervals for patients who 
have <50% lesions. 
The authors of the study just presented recommend at 
least annual follow-up for patients who have asymptomatic 
carotid stenosis associated with a PSV of 175 cm/sec or 
greater and follow-up after an interval of 3 to 4 years for 
patients who have a PSV less than 175 cm/sec. Although 
this study raises a number of interesting questions, I will 
limit my list to the following three. First, the mean fol- 
low-up interval for the entire group of 263 patients was 20 
months. What was the mean follow-up interval for the 246 
patients who had asymptomatic nternal carotid artery 
stenoses that remained at <60% compared with the mean 
follow-up interval for the 17 patients who had stenoses that 
progressed to ->60%? If these groups were observed for 
widely disparate intervals, this factor could account for some 
of the differences observed. Second, the manuscript refers 
to nine patients who did not undergo surgery after progres- 
sion to ->60% asymptomatic internal carotid stenosis was 
observed. Serial duplex follow-up of these patients demon- 
strated PSVs of 260 cm/sec or greater in 23 of 28 studies. 
Does this mean that evidence of disease regression was 
present in some of these cases? Third, the clinical factors of 
elevated systolic blood pressure and lower initial ABI 
correlated with asymptomatic progression to a ->60% ICA 
stenosis. Did these factors correlate with disease progression 
independent of the PSV? If so, should patients who have 
these risk factors be considered for more frequent duplex 
follow-up even if the PSV is less than 175 cm/sec? 
This report is a valuable contribution to our under- 
standing of the natural history of carotid artery disease, and 
the data presented will result in a more rational approach to 
the management of patients with less severe degrees of 
carotid stenosis. 
Dr. Mark IL Nehler. This work compares two sample 
groups that contain markedly different numbers of patients. 
Clearly, care must be taken to avoid a type II error in data 
analysis. The mean follow-up was similar in both groups: 18 
months in the patients who had asymptomatic ICA pro- 
gression to ->60% stenosis compared with 20 months for the 
patients whose asymptomatic ICAs remained <60%. 
The nine patients who were observed who did not 
undergo surgery after ICA progression without symptoms 
to ->60% stenosis had a total of 28 serial duplex examinations 
after progression. Two arteries had five duplex examinations 
that demonstrated PSVs lower than 260 cm/sec. These 
arteries represented either regression or were borderline 
lesions. 
The influence of initial elevated systolic blood pressure 
and resting ABI were analyzed independent of the duplex 
velocities. Our goal was to develop an algorithm that was 
simple to use. The mean values for the initial systolic blood 
pressure and the lowest resting ABI in the two groups were 
not markedly different, despite the p value of 0.05. 
Dr. Jerry Goldstone (San Francisco, Calif.). Dr. Whit- 
temore, what do you do at your vascular center in the 
greater Boston area? 
Dr. Anthony D. Whittemore (Boston, Mass.). With 
respect to carotid artery screening, cardiac surgeons seem to 
be divided even as to whether participation i the ongoing 
attempt to launch a multicenter t ial to answer that question 
is justified. Many reasons for that divided opinion have been 
brought out this morning, but perhaps the main point is 
that screening at least identifies a patient population at risk, 
and what that risk is during cardiac and noncardiac surgery 
is still controversial. 
Our philosophy is to screen patients who have severe 
claudlcation and other operative candidates, and those 
patients who undergo coronary bypass, with the under- 
standing that we may not be repairing lesions in the 60% to 
80% range, but we are at least identifying those patients at 
risk who require serial surveillance. 
Dr. D. Eugene Strandness, Jr. (Seattle, Wash.). I think 
there is an important point here. From our studies and 
others, we now know what to tell a patient. I think this is 
very important. We know that the progression rate is very 
low in certain groups and is higher in others. This is very 
valuable information. The only question I would have is to 
ask Dr. Porter whether he thinks old geezer vascular 
surgeons ought to be screened. 
Dr. John M. Porter. I think that we should be 
extremely kind to  geezers. There are more geezers being 
created every day. 
Dr. Strandness. The reason I bring this up, John, is 
because I do get scanned every ear by Ms. Jean Primozich, 
and I watch her eyes more than anything else. 
Dr. Porter. I don't know. I think this issue of screening 
is important. We like to screen all of our preoperative 
vascular patients who are having elective surgery. The issue 
of who's going to pay for the screening is a big-time 
problem, but we find a modest number of D-plus lesions in 
elective leg bypass, elective aneurysm patients, and insofar as 
the second surgery is elective, we recommend that the 
carotid artery be addressed first. 
Dr. Strandness. I think that it is nice to be able to tell 
the patient that they have disease in this particular category. 
We know what the rate of progression is. They don't have to 
be screened except once every year or two. I think this is 
important, and I can't hink of any information that's more 
comforting to a patient than saying, "Look, you don't have 
to worry about having a stroke from your carotid artery in 
the next 4 to 5 years." 
Dr. Nehler. The medical community has spent a great 
deal of resources on multicenter t ials to define the efficacy 
of carotid endarterectomy in asymptomatic patients who 
have appropriate l sions. Our job is to determine how to 
effectively locate patients who could potentially benefit 
from within our vascular population. 
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Dr. York N. Hsiang (Vancouver, British Columbia). 
That was a very nice study. I note that you were sponsored 
by the National Institutes of Health to look at a progression 
study. I was wondering ifyou were going to be sponsored by 
the same to look at a regression study. 
I think some of the things that you talked about focus on 
disease and not the whole patient. What were the patient 
characteristics of those patients who progressed and those 
patients who did not progress? 
In other words, what happened to the patients' moking 
status, their obesity status, and their cholesterol levels? Were 
they taking any antioxidants or any other medications that 
could regress atherosclerosis, in particular the calcium 
channel blockers? 
Dr. Nehler. Only initial lipid levels were measured in 
our protocol. We have no data regarding the other factors. 
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